Construction and characteristics of the RxRisk-V: a VA-adapted pharmacy-based case-mix instrument.
about
Subjective assessments of comorbidity correlate with quality of life health outcomes: initial validation of a comorbidity assessment instrument.Prognostic stratification of older persons based on simple administrative data: development and validation of the "Silver Code," to be used in emergency department triage.An in-depth assessment of a diagnosis-based risk adjustment model based on national health insurance claims: the application of the Johns Hopkins Adjusted Clinical Group case-mix system in TaiwanComparison of Rx-defined morbidity groups and diagnosis- based risk adjusters for predicting healthcare costs in Taiwan.The use and impact of cancer medicines in routine clinical care: methods and observations in a cohort of elderly AustraliansA methodological protocol for selecting and quantifying low-value prescribing practices in routinely collected data: an Australian case study.Determinants of generic drug substitution in Switzerland.Health care use and costs at the end of life: a comparison of elderly Australian decedents with and without a cancer historyThe geography of diabetes by census tract in a large sample of insured adults in King County, Washington, 2005-2006.Case-mix adjusting performance measures in a veteran population: pharmacy- and diagnosis-based approaches.Monitoring the prevalence of chronic conditions: which data should we use?Disease identification based on ambulatory drugs dispensation and in-hospital ICD-10 diagnoses: a comparisonAssociation of living alone and hospitalization among community-dwelling elders with and without dementia.The prevalence and ingredient cost of chronic comorbidity in the Irish elderly population with medication treated type 2 diabetes: a retrospective cross-sectional study using a national pharmacy claims databaseRanibizumab and risk of hospitalisation for ischaemic stroke and myocardial infarction in patients with age-related macular degeneration: a self-controlled case-series analysis.Proton pump inhibitors and the risk of pneumonia: a comparison of cohort and self-controlled case series designsPrevalence of multimorbidity according to the deprivation level among the elderly in the Basque Country.Resource use, costs and quality of end-of-life care: observations in a cohort of elderly Australian cancer decedents.Association of incident dementia with hospitalizationsComparing co-morbidities in total joint arthroplasty patients using the RxRisk-V, Elixhauser, and Charlson Measures: a cross-sectional evaluation.Relationship between Obesity, Depression, and Disability in Middle-Aged Women.Healthcare Utilization and Costs of Knee or Hip Replacements versus Pain-Relief Injections.COPD exacerbations associated with the modified Medical Research Council scale and COPD assessment test among Humana Medicare membersCosts of interstitial cystitis in a managed care population.Assessment of statin-associated muscle toxicity in Japan: a cohort study conducted using claims database and laboratory information.Patient Preferences Regarding Rheumatoid Arthritis Therapies: A Conjoint Analysis.Cost sharing and decreased branded oral anti-diabetic medication adherence among elderly Part D Medicare beneficiaries.Health service use and costs in the last 6 months of life in elderly decedents with a history of cancer: a comprehensive analysis from a health payer perspective.Association between statin use and risk for keratinocyte carcinoma in the veterans affairs topical tretinoin chemoprevention trial.Heart failure after conventional metal-on-metal hip replacements.Use and outcomes of targeted therapies in early and metastatic HER2-positive breast cancer in Australia: protocol detailing observations in a whole of population cohort.The geographic distribution of obesity by census tract among 59 767 insured adults in King County, WA.Impact of comorbid conditions in COPD patients on health care resource utilization and costs in a predominantly Medicare population.A Review on Methods of Risk Adjustment and their Use in Integrated Healthcare SystemsInappropriate prescribing in older fallers presenting to an Irish emergency department.Multimorbidity in Australia: Comparing estimates derived using administrative data sources and survey data.Retrospective analysis of outcomes following inferior vena cava (IVC) filter placement in a managed care population.Initiation of strong prescription opioids in Australia: cohort characteristics and factors associated with the type of opioid initiated.Predictors of reaching a serum uric acid goal in patients with gout and treated with febuxostat.The Impact of Medication-Based Risk Adjustment on the Association Between Veteran Health Outcomes and Dual Health System Use.
P2860
Q24813902-8417AC1F-27DD-468E-AADB-6BC036EDB1CFQ33427357-16356582-9637-43A1-A736-4040EE83DE43Q33524889-41D27A72-4FB9-4A6F-A9B0-A13758EA90A7Q33579539-D473B8BA-A6B1-443B-A1F6-B92C0216A0F0Q33629327-29031EC9-F6A2-4DC2-B99E-B1F63FEBB5FEQ33634843-9CACA00C-CD22-4A4F-80B8-2855970D04F1Q33804307-C57421B9-C2C1-4D19-A40C-94F7E73956ACQ33823448-E86798F2-99F0-4669-8CBE-27C682B81820Q33958992-B54C8463-6DE2-49C2-A7BD-6BEB6B4EDF02Q34336060-E353AAE9-CBE6-4B82-AF8F-6A33FFA0AE28Q34454333-A543C8D4-5BA7-47F2-9EF0-55FDA556A6B7Q34493849-F73A679C-6438-4D2B-83C7-75430327DC91Q34546478-8AF549EC-8AD3-4E0D-8413-1CC11D6A83B7Q34550144-1A187AD8-A9C2-48C6-A913-C4ECFAEC418CQ34567356-EE00337D-E6C4-4390-92E1-11C0F7C288A3Q34783099-E31CF4B4-6827-4FAB-8EC7-F483D53F04B7Q35006912-0C2E3DD7-42BC-45CD-A8F3-B7BBB85F2E36Q35149401-A9D7DC58-F90D-4A45-9395-E7F8EED50C23Q35854471-BF13C63B-1A7D-460F-85AC-689ABC6FFC9CQ35864928-63B4918E-5868-46E1-BADC-D114ED614FEFQ36163012-0222EDDF-176D-4A72-9DC5-73081B6287DBQ36257550-570D8E70-B38A-4D00-9F2C-542214F0713DQ36473543-C6284433-BCE0-42DA-9F33-EF27C41C6B09Q36724232-610C7333-FD3C-4FDF-8F48-A4C43EAF8940Q36809811-3AABA998-65D0-4A3F-B3C0-8DA1CF9B7422Q36868373-218326CB-BC32-4790-8166-6964BAB635FCQ36927439-CAC8748A-7A8E-4F88-A059-7AAEFF246AECQ36964343-926EAF90-785C-497C-A725-AC88FE4F7CBBQ37167232-647A429E-FEDC-4682-8B80-E2E6A9764B1BQ37597154-9E81BEF2-5FC9-4721-9C85-33663E9872D0Q37612139-66AD6982-F68D-4798-AA7E-2684EF1A805AQ37640044-53C78A90-BF14-4095-A2C5-FAF822AB452EQ37669183-5CBC390E-1162-4F97-A7EE-88F61F88788AQ37705385-10078B00-C7FF-471F-8739-34C260F08396Q38127491-F1880653-29BF-4598-90D0-AE9D2125A537Q38603789-C7529C9A-E15E-45B5-B226-85B0CC2B95B2Q38760489-CEEDC19A-5AC6-4584-8D53-86EE015E42E6Q39710590-9833915F-5F80-45CB-B765-01F49A5A84B6Q42688139-9A4DD8B9-FF44-400E-875C-C293580A3E4CQ45326670-58A046F9-F576-4C69-A5A5-A232C4DB820B
P2860
Construction and characteristics of the RxRisk-V: a VA-adapted pharmacy-based case-mix instrument.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Construction and characteristi ...... acy-based case-mix instrument.
@ast
Construction and characteristi ...... acy-based case-mix instrument.
@en
type
label
Construction and characteristi ...... acy-based case-mix instrument.
@ast
Construction and characteristi ...... acy-based case-mix instrument.
@en
prefLabel
Construction and characteristi ...... acy-based case-mix instrument.
@ast
Construction and characteristi ...... acy-based case-mix instrument.
@en
P2093
P1433
P1476
Construction and characteristi ...... acy-based case-mix instrument.
@en
P2093
Anne E Sales
Chuan-Fen Liu
Kevin L Sloan
Nancy D Sharp
Norman T Suzuki
Paul Fishman
Paul Nichol
P304
P356
10.1097/00005650-200306000-00009
P577
2003-06-01T00:00:00Z